- Dosed first patient in SURF302 for intermediate risk non-muscle invasive bladder cancer (IR NMIBC) -
- Cash, cash equivalents, and marketable securities of $296.3...
AVANT BIO nominated by the prestigious Foundation Galien for the Prix Galien Award in the "Incubators, Accelerators and Equity" category.Unique distinction of having a portfolio...
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
- Profitability initiatives drive margin expansion; Location count surpasses 1,000 early...